August 4 (SeeNews) - Bulgarian pharmaceuticals maker Sopharma [BUL:SFA] said that its standalone net profit went up to 23.6 million levs ($ 12.3 million/12.1 million euro) in the first half of 2022 from just over 12 million levs a year earlier.